Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Clinical and translational medicine - 13(2023), 7 vom: 25. Juli, Seite e1349 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhou, Xinping [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 27.07.2023 Date Revised 29.07.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/ctm2.1349 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359919006 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359919006 | ||
| 003 | DE-627 | ||
| 005 | 20231226081912.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ctm2.1349 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1199.xml |
| 035 | |a (DE-627)NLM359919006 | ||
| 035 | |a (NLM)37491737 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhou, Xinping |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.07.2023 | ||
| 500 | |a Date Revised 29.07.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Circulating Tumor DNA |2 NLM | |
| 700 | 1 | |a Lang, Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Mei, Chen |e verfasserin |4 aut | |
| 700 | 1 | |a Ren, Yanling |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Liya |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Lingxu |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Gaixiang |e verfasserin |4 aut | |
| 700 | 1 | |a Luo, Yingwan |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Lixia |e verfasserin |4 aut | |
| 700 | 1 | |a Cao, Shanbo |e verfasserin |4 aut | |
| 700 | 1 | |a Qin, Jiayue |e verfasserin |4 aut | |
| 700 | 1 | |a Tong, Hongyan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and translational medicine |d 2012 |g 13(2023), 7 vom: 25. Juli, Seite e1349 |w (DE-627)NLM224642685 |x 2001-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:7 |g day:25 |g month:07 |g pages:e1349 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ctm2.1349 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 7 |b 25 |c 07 |h e1349 | ||